Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 10, 2012

GE Healthcare Supplies Refine Tech with Filtration Cartridges for ATF Cell Retention System

  • GE Healthcare is to supply Refine Technologies with its hollow fiber filtration cartridges for use with the latter’s ATF™ system, a cell retention device based on alternating tangential flow technology, which is used for a range of biomanufacturing applications. The firms say the distribution agreement will help set the stage for future collaboration in the field of biomanufacturing.

    Refine’s flagship ATF system is designed to generate extremely high concentrations of cells that can then be collected for further processing. The firm says continuous processing demonstrates advantages over batch manufacturing, including faster cell isolation and shorter manufacturing times.

    The platform can also be customized for application in small laboratory-scale production, through to commercial manufacturing. Applications range from simple culture maintenance to the generation of extreme cultures, and vaccine manufacturing, Refine adds. 

    In January the firm inked a collaboration agreement with Sartorius Stedim Biotech, to develop a high-density cell cultivation platform that will allow connection of the ATF system to SSB’s single-use Biostat® bioreactors. 



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »